Prabhudas Lilladher's research report on Ahluwalia Contracts (India)
Ahluwalia Contracts (ACIL) posted strong results in 4Q, with beat on both revenue (up 38.7% YoY) and margin front. Execution witnessed some headwinds amidst Covid second wave, when labour availability across project sites fell to ~30% levels, but improved substantially with ease in lockdown restrictions and fall in cases. Though it is yet to reach pre-covid levels in many sites. Even with healthy order book and rising execution pace, management gave conservative guidance of 10-15% revenue growth in FY22 considering headwinds of second wave (and a possible third wave). EBITDAM is expected to be in 11-12% range, given major provisioning now complete.
Outlook
At CMP, the stock trades at a P/E of 17.6x/ 12.2x on FY22E/ 23E EPS and is trading at an EV of 8.9x/ 6.6x FY22E/ 23E EBITDA. Due to recent sharp run-up in stock price, we downgrade from ‘BUY’ to ‘ACCUMULATE’ with a TP of Rs410 (Earlier TP of Rs384).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!